Skip to main content
Clinical Trials/NCT02177539
NCT02177539
Unknown
Phase 4

A New More Efficient Cycloplegia Scheme

Pontificia Universidad Catolica de Chile1 site in 1 country30 target enrollmentMay 2014

Overview

Phase
Phase 4
Intervention
Cyclopentolate
Conditions
Refractive Errors
Sponsor
Pontificia Universidad Catolica de Chile
Enrollment
30
Locations
1
Primary Endpoint
Change in Spherical equivalent
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine whether tropicamide + phenylephrine cyclopentolate + applied for once waiting 30 minutes to retinoscopy (new scheme) is not inferior to apply cyclopentolate alone and wait 45 minutes to retinoscopy (traditional scheme)

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
September 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children between 1 and 10 years

Exclusion Criteria

  • Strabismus
  • Ocular surgery
  • Another ocular disease than ametropias (i.e uveitis, cataract)
  • Cardiovascular or neurologic disease.
  • Allergy to any of drugs used in the study

Arms & Interventions

Cyclopentolate

Intervention: Cyclopentolate

Cyclopentolate

Intervention: Cyclopentolate+tropicamide+phenylephrine

Cyclopentolate+tropicamide+phenylephrine

Intervention: Cyclopentolate

Cyclopentolate+tropicamide+phenylephrine

Intervention: Cyclopentolate+tropicamide+phenylephrine

Outcomes

Primary Outcomes

Change in Spherical equivalent

Time Frame: average 18 days

In the first and second visit the spherical equivalent will be measured with retinoscopy. Change in spherical equivalent refraction from first visit to day average 18 days (second visit). On both visits the patient will receive different cyclopegia schemes.

Secondary Outcomes

  • Change in spherical refraction(average 18 days)
  • Change in cylindrical refraction(average 18 days)
  • iris motility(average 18 days)

Study Sites (1)

Loading locations...

Similar Trials